Degradome products of the matricellular protein CCN1 as modulators of pathological angiogenesis in the retina

Journal of Biological Chemistry

Volumn 288, Issue 32, 2013, Pages 23075-23089

  Choi, Jinok ^a   Lin, Ann ^a   Shrier, Eric ^a   Lau, Lester F ^b   Grant, Maria B ^c   Chaqour, Brahim ^a  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b UNIVERSITY OF ILLINOIS   (United States)

^c UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS; DEGRADATION PRODUCTS; ISCHEMIC CONDITIONS; MATRICELLULAR PROTEIN; POTENTIAL TARGETS; PROTEOLYTIC DEGRADATION; RETINAL NEOVASCULARIZATION; VASCULAR DEVELOPMENT;

DEGRADATION;

OPHTHALMOLOGY;

CYSTEINE RICH PROTEIN 61; GELATINASE A; MATRIX METALLOPROTEINASE 14; SOMATOMEDIN BINDING PROTEIN 1; THROMBOSPONDIN 1; TUMOR NECROSIS FACTOR ALPHA;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANGIOGENESIS; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL FUNCTION; CELL GROWTH; DIABETIC RETINOPATHY; EXTRACELLULAR MATRIX; GENE EXPRESSION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; QUANTITATIVE ANALYSIS; RETINA NEOVASCULARIZATION; RNA ISOLATION; VITREOUS BODY; WESTERN BLOTTING;

ANGIOGENESIS; CYSTEINE-RICH PROTEIN 61 (CCN1); ENDOTHELIAL CELL; EXTRACELLULAR MATRIX PROTEINS; ISCHEMIA; MATRICELLULAR PROTEIN; MATRIX METALLOPROTEINASE (MMP); PROTEIN DEGRADATION; PROTEIN DOMAINS; RETINA;

ANIMALS; BIOLOGICAL MARKERS; CELL LINE; CYSTEINE-RICH PROTEIN 61; DIABETIC RETINOPATHY; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; MICE; NEOVASCULARIZATION, PATHOLOGIC; PROTEIN FOLDING; PROTEIN STRUCTURE, TERTIARY; PROTEOLYSIS; RATS; THROMBOSPONDIN 1; VON WILLEBRAND FACTOR;

EID: 84881418074     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.475418     Document Type: Article

References (60)

1. Bradley, J., Ju, M., and Robinson, G. S. (2007) Combination therapy for the treatment of ocular neovascularization. Angiogenesis 10, 141-148
2. Rivera, J. C., Sapieha, P., Joyal, J. S., Duhamel, F., Shao, Z., Sitaras, N., Picard, E., Zhou, E., Lachapelle, P., and Chemtob, S. (2011) Understanding retinopathy of prematurity: update on pathogenesis. Neonatology 100, 343-353
3. Lu, P., Takai, K., Weaver, V. M., and Werb, Z. (2011) Extracellular matrix degradation and remodeling in development and disease. Cold Spring Harbor Perspect. Biol. 3, 1-24
4. Senger, D. R., and Davis, G. E. (2011) Angiogenesis. Cold Spring Harbor Perspect. Biol. 3, a005090
5. Boosani, C. S., and Sudhakar, Y. A. (2011) Proteolytically derived endogenous angioinhibitors originating from the extracellular matrix. Pharmaceuticals 4, 1551-1577
6. Jun, J. I., and Lau, L. F. (2011) Taking aim at the extracellular matrix: CCN proteins as emerging therapeutic targets. Nat. Rev. Drug Discov. 10, 945-963
7. Hasan, A., Pokeza, N., Shaw, L., Lee, H. S., Lazzaro, D., Chintala, H., Rosenbaum, D., Grant, M. B., and Chaqour, B. (2011) The matricellular protein cysteine-rich protein 61 (CCN1/Cyr61) enhances physiological adaptation of retinal vessels and reduces pathological neovascularization associated with ischemic retinopathy. J. Biol. Chem. 286, 9542-9554
8. Hilfiker-Kleiner, D., Kaminski, K., Kaminska, A., Fuchs, M., Klein, G., Podewski, E., Grote, K., Kiian, I., Wollert, K. C., Hilfiker, A., and Drexler, H. (2004) Regulation of proangiogenic factor CCN1 in cardiac muscle: impact of ischemia, pressure overload, and neurohumoral activation. Circulation 109, 2227-2233
9. Jin, Y., Kim, H. P., Ifedigbo, E., Lau, L. F., and Choi, A. M. (2005) Cyr61 protects against hyperoxia-induced cell death via Akt pathway in pulmonary epithelial cells. Am. J. Respir. Cell Mol. Biol. 33, 297-302
10. Kubota, S., and Takigawa, M. (2007) CCN family proteins and angiogenesis: from embryo to adulthood. Angiogenesis 10, 1-11
11. Hughes, J. M., Kuiper, E. J., Klaassen, I., Canning, P., Stitt, A. W., Van Bezu, J., Schalkwijk, C. G., Van Noorden, C. J., and Schlingemann, R. O. (2007) Advanced glycation end products cause increased CCN family and extracellular matrix gene expression in the diabetic rodent retina. Diabetologia 50, 1089-1098
12. Yan, L., and Chaqour, B. (2013) Cysteine-rich protein 61 (CCN1) and connective tissue growth factor (CCN2) at the crosshairs of ocular neovascular and fibrovascular disease therapy. J. Cell Commun. Signal. 10.1007/s12079-013- 0206-6
13. KivelA, R., Silvennoinen, M., Lehti, M., Jalava, S., Vihko, V., and Kainulainen, H. (2008) Exercise-induced expression of angiogenic growth factors in skeletal muscle and in capillaries of healthy and diabetic mice. Cardiovasc. Diabetol. 7, 13
14. Zhang, X., Yu, W., and Dong, F. (2012) Cysteine-rich 61 (CYR61) is upregulated in proliferative diabetic retinopathy. Graefes Arch. Clin. Exp. Ophthalmol. 250, 661-668
15. O'Leary, J. M., Hamilton, J. M., Deane, C. M., Valeyev, N. V., Sandell, L. J., and Downing, A. K. (2004) Solution structure and dynamics of a prototypical chordin-like cysteine-rich repeat (von Willebrand factor type C module) from collagen IIA. J. Biol. Chem. 279, 53857-53866
16. Chen, C. C., and Lau, L. F. (2009) Functions and mechanisms of action of CCN matricellular proteins. Int. J. Biochem. Cell Biol. 41, 771-783
17. Gao, R., and Brigstock, D. R. (2003) Low density lipoprotein receptorrelated protein (LRP) is a heparin-dependent adhesion receptor for connective tissue growth factor (CTGF) in rat activated hepatic stellate cells. Hepatol. Res. 27, 214-220
18. Leask, A., and Abraham, D. J. (2006) All in the CCN family: essential matricellular signaling modulators emerge from the bunker. J. Cell Sci. 119, 4803-4810
19. Leu, S. J., Lam, S. C., and Lau, L. F. (2002) Pro-angiogenic activities of CYR61 (CCN1) mediated through integrinsv3 and61 in human umbilical vein endothelial cells. J. Biol. Chem. 277, 46248-46255
20. Leu, S. J., Liu, Y., Chen, N., Chen, C. C., Lam, S. C., and Lau, L. F. (2003) Identification of a novel integrin61-binding site in the angiogenic inducer CCN1 (CYR61). J. Biol. Chem. 278, 33801-33808
21. Schober, J. M., Chen, N., Grzeszkiewicz, T. M., Jovanovic, I., Emeson, E. E., Ugarova, T. P., Ye, R. D., Lau, L. F., and Lam, S. C. (2002) Identification of integrinM2 as an adhesion receptor on peripheral blood monocytes for Cyr61 (CCN1) and connective tissue growth factor (CCN2): immediateearly gene products expressed in atherosclerotic lesions. Blood 99, 4457-4465
22. Segarini, P. R., Nesbitt, J. E., Li, D., Hays, L. G., Yates, J. R., 3rd, and Carmichael, D. F. (2001) The low density lipoprotein receptor-related protein/2-macroglobulin receptor is a receptor for connective tissue growth factor. J. Biol. Chem. 276, 40659-40667
23. Liu, H., Yang, R., Tinner, B., Choudhry, A., Schutze, N., and Chaqour, B. (2008) Cysteine-rich protein 61 and connective tissue growth factor induce deadhesion and anoikis of retinal pericytes. Endocrinology 149, 1666-1677
24. Athanasopoulos, A. N., Schneider, D., Keiper, T., Alt, V., Pendurthi, U. R., Liegibel, U. M., Sommer, U., Nawroth, P. P., Kasperk, C., and Chavakis, T. (2007) Vascular endothelial growth factor (VEGF)-induced up-regulation of CCN1 in osteoblasts mediates proangiogenic activities in endothelial cells and promotes fracture healing. J. Biol. Chem. 282, 26746-26753
25. Latinkic, B. V., Mercurio, S., Bennett, B., Hirst, E. M., Xu, Q., Lau, L. F., Mohun, T. J., and Smith, J. C. (2003) Xenopus Cyr61 regulates gastrulation movements and modulates Wnt signalling. Development 130, 2429-2441
26. Zhou, D., Herrick, D. J., Rosenbloom, J., and Chaqour, B. (2005) Cyr61 mediates the expression of VEGF,v-integrin, and-actin genes through cytoskeletally based mechanotransduction mechanisms in bladder smooth muscle cells. J. Appl. Physiol. 98, 2344-2354
27. Grote, K., Salguero, G., Ballmaier, M., Dangers, M., Drexler, H., and Schieffer, B. (2007) The angiogenic factor CCN1 promotes adhesion and migration of circulating CD34progenitor cells: potential role in angiogenesis and endothelial regeneration. Blood 110, 877-885
28. Schütze, N., Schenk, R., Fiedler, J., Mattes, T., Jakob, F., and Brenner, R. E. (2007) CYR61/CCN1 and WISP3/CCN6 are chemoattractive ligands for human multipotent mesenchymal stroma cells. BMC Cell Biol. 8, 45
29. Butler, J. M., Guthrie, S. M., Koc, M., Afzal, A., Caballero, S., Brooks, H. L., Mames, R. N., Segal, M. S., Grant, M. B., and Scott, E. W. (2005) SDF-1 is both necessary and sufficient to promote proliferative retinopathy. J. Clin. Invest. 115, 86-93
30. Shi, F., and Sottile, J. (2011) MT1-MMP regulates the turnover and endocytosis of extracellular matrix fibronectin. J. Cell Sci. 124, 4039-4050
31. MacKenzie, T. C., Kobinger, G. P., Kootstra, N. A., Radu, A., Sena-Esteves, M., Bouchard, S., Wilson, J. M., Verma, I. M., and Flake, A. W. (2002) Efficient transduction of liver and muscle after in utero injection of lentiviral vectors with different pseudotypes. Mol. Ther. 6, 349-358
32. Chintala, H., Liu, H., Parmar, R., Kamalska, M., Kim, Y. J., Lovett, D., Grant, M. B., and Chaqour, B. (2012) Connective tissue growth factor regulates retinal neovascularization through p53 protein-dependent transactivation of the matrix metalloproteinase (MMP)-2 gene. J. Biol. Chem. 287, 40570-40585
33. Smith, L. E., Wesolowski, E., McLellan, A., Kostyk, S. K., D'Amato, R., Sullivan, R., and D'Amore, P. A. (1994) Oxygen-induced retinopathy in the mouse. Invest. Ophthalmol. Vis. Sci. 35, 101-111
34. Zudaire, E., Gambardella, L., Kurcz, C., and Vermeren, S. (2011) A computational tool for quantitative analysis of vascular networks. PLoS One 6, e27385
35. Tamura, I., Rosenbloom, J., Macarak, E., and Chaqour, B. (2001) Regulation of Cyr61 gene expression by mechanical stretch through multiple signaling pathways. Am. J. Physiol. Cell Physiol. 281, C1524-C1532
36. van Wijngaarden, P., Brereton, H. M., Coster, D. J., and Williams, K. A. (2007) Stability of housekeeping gene expression in the rat retina during exposure to cyclic hyperoxia. Mol. Vis. 13, 1508-1515
37. Roy, A., Kucukural, A., and Zhang, Y. (2010) I-TASSER: a unified platform for automated protein structure and function prediction. Nat. Protoc. 5, 725-738
38. Wang, H., Feng, L., Hu, J., Xie, C., and Wang, F. (2013) Differentiating vitreous proteomes in proliferative diabetic retinopathy using high-performance liquid chromatography coupled to tandem mass spectrometry. Exp. Eye Res. 108, 110-119
39. Dean, R. A., Butler, G. S., Hamma-Kourbali, Y., Delbé, J., Brigstock, D. R., Courty, J., and Overall, C. M. (2007) Identification of candidate angiogenic inhibitors processed by matrix metalloproteinase 2 (MMP-2) in cell-based proteomic screens: disruption of vascular endothelial growth factor (VEGF)/heparin affin regulatory peptide (pleiotrophin) and VEGF/connective tissue growth factor angiogenic inhibitory complexes by MMP-2 proteolysis. Mol. Cell. Biol. 27, 8454-8465
40. Butler, G. S., Dean, R. A., Tam, E. M., and Overall, C. M. (2008) Pharmacoproteomics of a metalloproteinase hydroxamate inhibitor in breast cancer cells: dynamics of membrane type 1 matrix metalloproteinase-mediated membrane protein shedding. Mol. Cell. Biol. 28, 4896-4914
41. Song, J., Tan, H., Perry, A. J., Akutsu, T., Webb, G. I., Whisstock, J. C., and Pike, R. N. (2012) PROSPER: an integrated feature-based tool for predicting protease substrate cleavage sites. PLoS One 7, e50300
42. Sato, H., Takino, T., Okada, Y., Cao, J., Shinagawa, A., Yamamoto, E., and Seiki, M. (1994) A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 370, 61-65
43. Perbal, B. (2009) Alternative splicing ofCCNmRNAs. It has been upon us. J. Cell Commun. Signal. 3, 153-157
44. Scott, A., and Fruttiger, M. (2010) Oxygen-induced retinopathy: a model for vascular pathology in the retina. Eye 24, 416-421
45. Karagiannis, E. D., and Popel, A. S. (2008) A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells. Proc. Natl. Acad. Sci. U.S.A. 105, 13775-13780
46. Guillon-Munos, A., Oikonomopoulou, K., Michel, N., Smith, C. R., Petit-Courty, A., Canepa, S., Reverdiau, P., Heuzé-Vourc'h, N., Diamandis, E. P., and Courty, Y. (2011) Kallikrein-related peptidase 12 hydrolyzes matricellular proteins of the CCN family and modifies interactions of CCN1 and CCN5 with growth factors. J. Biol. Chem. 286, 25505-25518
47. Pendurthi, U. R., Tran, T. T., Post, M., and Rao, L. V. (2005) Proteolysis of CCN1 by plasmin: functional implications. Cancer Res. 65, 9705-9711
48. Overall, C. M., and Blobel, C. P. (2007) In search of partners: linking extracellular proteases to substrates. Nat. Rev. Mol. Cell Biol. 8, 245-257
49. d'Ortho, M. P., Will, H., Atkinson, S., Butler, G., Messent, A., Gavrilovic, J., Smith, B., Timpl, R., Zardi, L., and Murphy, G. (1997) Membrane-type matrix metalloproteinases 1 and 2 exhibit broad-spectrum proteolytic capacities comparable with many matrix metalloproteinases. Eur. J. Biochem. 250, 751-757
50. Martino, M. M., and Hubbell, J. A. (2010) The 12th-14th type III repeats of fibronectin function as a highly promiscuous growth factor-binding domain. FASEB J. 24, 4711-4721
51. Elzie, C. A., and Murphy-Ullrich, J. E. (2004) The N terminus of thrombospondin: the domain stands apart. Int. J. Biochem. Cell Biol. 36, 1090-1101
52. Huwiler, K. G., Vestling, M. M., Annis, D. S., and Mosher, D. F. (2002) Biophysical characterization, including disulfide bond assignments, of the anti-angiogenic type 1 domains of human thrombospondin-1. Biochemistry 41, 14329-14339
53. Inoki, I., Shiomi, T., Hashimoto, G., Enomoto, H., Nakamura, H., Makino, K., Ikeda, E., Takata, S., Kobayashi, K., and Okada, Y. (2002) Connective tissue growth factor binds vascular endothelial growth factor (VEGF) and inhibits VEGF-induced angiogenesis. FASEB J. 16, 219-221
54. Ishida, S., Usui, T., Yamashiro, K., Kaji, Y., Amano, S., Ogura, Y., Hida, T., Oguchi, Y., Ambati, J., Miller, J. W., Gragoudas, E. S., Ng, Y. S., D'Amore, P. A., Shima, D. T., and Adamis, A. P. (2003) VEGF164-mediated inflammation is required for pathological, but not physiological, ischemia-induced retinal neovascularization. J. Exp. Med. 198, 483-489
55. Bork, P. (1993) The modular architecture of a new family of growth regulators related to connective tissue growth factor. FEBS Lett. 327, 125-130
56. Brigstock, D. R. (2003) The CCN family: a new stimulus package. J. Endocrinol. 178, 169-175
57. Holbourn, K. P., Acharya, K. R., and Perbal, B. (2008) The CCN family of proteins: structure-function relationships. Trends Biochem. Sci. 33, 461-473
58. Fukushima, Y., Okada, M., Kataoka, H., Hirashima, M., Yoshida, Y., Mann, F., Gomi, F., Nishida, K., Nishikawa, S., and Uemura, A. (2011) Sema3EPlexinD1 signaling selectively suppresses disoriented angiogenesis in ischemic retinopathy in mice. J. Clin. Invest. 121, 1974-1985
59. Schlingemann, R. O., Rietveld, F. J., Kwaspen, F., van de Kerkhof, P. C., de Waal, R. M., and Ruiter, D. J. (1991) Differential expression of markers for endothelial cells, pericytes, and basal lamina in the microvasculature of tumors and granulation tissue. Am. J. Pathol. 138, 1335-1347
60. Koziol, A., Gonzalo, P., Mota, A., Pollán, Á., Lorenzo, C., Colomé, N., Montaner, D., Dopazo, J., Arribas, J., Canals, F., and Arroyo, A. G. (2012) The protease MT1-MMP drives a combinatorial proteolytic program in activated endothelial cells. FASEB J. 26, 4481-4494